Associations between the HDL-C/ApoA-I ratio and fasting glucose levels differ by glucose deciles, HDL-C/ApoA-I ratio ranges and sex

To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional study was performed in 97,801 males and 70,773 females without known disease. The ratio of HDL-C/ApoA-I is more stable for predicting fasting g...

Full description

Saved in:
Bibliographic Details
Published inDiabetes research and clinical practice Vol. 190; p. 110021
Main Authors Zhang, Yuetao, Wang, Yue
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional study was performed in 97,801 males and 70,773 females without known disease. The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels. The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis.
AbstractList To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).AIMSTo learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).A cross-sectional study was performed in 97,801 males and 70,773 females without known disease.METHODSA cross-sectional study was performed in 97,801 males and 70,773 females without known disease.The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels.RESULTSThe ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels.The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis.CONCLUSIONSThe HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis.
To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional study was performed in 97,801 males and 70,773 females without known disease. The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels. The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis.
ArticleNumber 110021
Author Zhang, Yuetao
Wang, Yue
Author_xml – sequence: 1
  givenname: Yuetao
  surname: Zhang
  fullname: Zhang, Yuetao
  organization: Health Management Center, Taizhou Central Hospital (Taizhou University Hospital), No. 999 Donghai Avenue, Taizhou Economic Development Zone, Taizhou, Zhejiang Province 318000, PR China
– sequence: 2
  givenname: Yue
  surname: Wang
  fullname: Wang, Yue
  email: euy-tokyo@umin.ac.jp
  organization: High Dimensional Digital Medicine Division, Biovisualab, Lotus International Plaza, 7866 Humin Road, Shanghai 201102, PR China
BookMark eNqNkEtrGzEURkVJoU7an1DQsouMI2nehBCMmzYBQzftWuhxx5WrSI6unMTr_vGM7dBFKCQrCfSdAzrH5CjEAIR85mzKGW_OVlPrlE6AU8GEmHLOmODvyIR3rSg6IdojMhl33f7-gRwjrhhjTVnVE_J3hhiNU9nFgFRDfgAINP8Gev11UczPZus4K25o2g2oCpYOCrMLS7r0GxMRqId78EitGwZIVG__PVgwzgOe_k-UVFgC7n0Ijx_J-0F5hE_P5wn59e3q5_y6WPz4fjOfLQpT9k0uWlMxq1veaKP7ahBg6q7tmrLtRc2qqmTQic5qW2kt7NAPtR0_KTRXthesrJvyhHw5eNcp3m0As7x1aMB7FSBuUIqmr_qm7NtynNaHqUkRMcEg18ndqrSVnMlddLmSz9HlLro8RB-58xeccXkfNyfl_Kv05YEei8K9gyTROAgGrEtgsrTRvWq4eGEw3gVnlP8D2zfwT3V8tlg
CitedBy_id crossref_primary_10_1016_j_numecd_2022_09_004
crossref_primary_10_1186_s12944_024_02281_z
Cites_doi 10.1001/archinte.167.10.1068
10.2337/diacare.28.8.2013
10.2337/db14-1603
10.1373/clinchem.2012.196949
10.1016/j.cocis.2005.11.006
10.1016/S0022-2275(20)41338-0
10.2337/dc14-0645
10.1038/s41569-021-00538-z
10.1056/NEJMoa1300955
10.3390/cells10040850
10.1210/jc.2013-1680
10.14797/mdcj-15-1-55
10.1007/s00125-020-05320-3
10.2337/db09-1114
10.1056/NEJMoa1706444
10.1097/MED.0000000000000139
10.1038/nsmb.2028
10.1161/CIRCULATIONAHA.108.843219
10.1093/cvr/cvu143
10.1530/EJE-14-0195
10.2337/diabetes.52.2.453
10.1001/jamacardio.2018.2112
10.1001/jamacardio.2018.2121
10.1161/CIRCRESAHA.119.312617
10.1038/nrendo.2011.235
10.1210/jc.2019-01080
10.1016/S0140-6736(12)60312-2
10.2337/dc21-Sint
ContentType Journal Article
Copyright 2022 Elsevier B.V.
Copyright © 2022 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2022 Elsevier B.V.
– notice: Copyright © 2022 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.diabres.2022.110021
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-8227
ExternalDocumentID 10_1016_j_diabres_2022_110021
S016882272200835X
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29F
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LZ1
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
WUQ
X7M
Z5R
ZGI
~G-
AACTN
AAIAV
ABLVK
ABYKQ
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
DOVZS
EFLBG
LCYCR
RIG
ZA5
AAYXX
AFCTW
AGRNS
CITATION
7X8
ID FETCH-LOGICAL-c396t-7c40db716bcb94f2ec587863792504430e828dbd4bb2df9f5d0062b1ad9203563
IEDL.DBID .~1
ISSN 0168-8227
1872-8227
IngestDate Fri Jul 11 06:47:14 EDT 2025
Tue Jul 01 01:02:54 EDT 2025
Thu Apr 24 22:51:09 EDT 2025
Fri Feb 23 02:40:14 EST 2024
Tue Aug 26 16:32:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Quantile regression
HDL-C/ApoA-I ratio
Fasting glucose
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c396t-7c40db716bcb94f2ec587863792504430e828dbd4bb2df9f5d0062b1ad9203563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2694963973
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2694963973
crossref_primary_10_1016_j_diabres_2022_110021
crossref_citationtrail_10_1016_j_diabres_2022_110021
elsevier_sciencedirect_doi_10_1016_j_diabres_2022_110021
elsevier_clinicalkey_doi_10_1016_j_diabres_2022_110021
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2022
2022-08-00
20220801
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: August 2022
PublicationDecade 2020
PublicationTitle Diabetes research and clinical practice
PublicationYear 2022
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Schmidt, Duncan, Bang, Pankow, Ballantyne, Golden (b0055) 2005; 28
Lee, Kim, Park (b0050) 2019; 104
German, Smilowitz, Zivkovic (b0120) 2006; 11
Davidson, Shah (b0095) 2019; 15
1217-27.
Garvey, Kwon, Zheng, Shaughnessy, Wallace, Hutto (b0130) 2003; 52
Cochran, Ong, Manandhar, Rye (b0045) 2021; 10
Huang, Silva, Jerome, Kontush, Chapman, Curtiss (b0010) 2011; 18
203-12.
Drew, Rye, Duffy, Barter, Kingwell (b0005) 2012; 8
Hwang, Ahn, Park, Park (b0080) 2014; 171
Kunitake, Mendel, Hennessy (b0110) 1992; 33
Oda (b0090) 2015; 22
Mora, Otvos, Rosenson, Pradhan, Buring, Ridker (b0135) 2010; 59
Mackey, Mora, Bertoni, Wassel, Carnethon, Sibley (b0140) 2015; 38
Mazer, Giulianini, Paynter, Jordan, Mora (b0105) 2013; 59
HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014
HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017
Introduction: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021
Ouimet, Barrett, Fisher (b0020) 2019; 124
Feingold KR. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from
Grundy, Stone, Bailey (b0150) 2019; 139
Pownall, Rosales, Gillard, Gotto (b0015) 2021; 18
Voight, Peloso, Orho-Melander, Frikke-Schmidt, Barbalic, Jensen (b0040) 2012; 380
Drew, Duffy, Formosa, Natoli, Henstridge, Penfold (b0070) 2009; 119
Nicholls, Andrews, Kastelein, Merkely, Nissen, Ray (b0035) 2018; 3
Abbasi, Corpeleijn, Gansevoort (b0065) 2013; 98
von Eckardstein, Widmann (b0100) 2014; 103
.
S1–S2.
Haase, Tybjærg-Hansen, Nordestgaard, Frikke-Schmidt (b0085) 2015; 64
Ahmed, Byrne, Pazderska, Segurado, Guo, Gunness (b0125) 2021; 64
Nicholls, Puri, Ballantyne, Jukema, Kastelein, Koenig (b0030) 2018; 3
Wilson, Meigs, Sullivan, Fox, Nathan, D'Agostino (b0060) 2007; 167
Mora (10.1016/j.diabres.2022.110021_b0135) 2010; 59
Huang (10.1016/j.diabres.2022.110021_b0010) 2011; 18
Voight (10.1016/j.diabres.2022.110021_b0040) 2012; 380
Schmidt (10.1016/j.diabres.2022.110021_b0055) 2005; 28
10.1016/j.diabres.2022.110021_b0075
Mazer (10.1016/j.diabres.2022.110021_b0105) 2013; 59
German (10.1016/j.diabres.2022.110021_b0120) 2006; 11
Drew (10.1016/j.diabres.2022.110021_b0005) 2012; 8
Abbasi (10.1016/j.diabres.2022.110021_b0065) 2013; 98
Hwang (10.1016/j.diabres.2022.110021_b0080) 2014; 171
Pownall (10.1016/j.diabres.2022.110021_b0015) 2021; 18
von Eckardstein (10.1016/j.diabres.2022.110021_b0100) 2014; 103
Nicholls (10.1016/j.diabres.2022.110021_b0030) 2018; 3
10.1016/j.diabres.2022.110021_b0025
10.1016/j.diabres.2022.110021_b0145
Drew (10.1016/j.diabres.2022.110021_b0070) 2009; 119
Wilson (10.1016/j.diabres.2022.110021_b0060) 2007; 167
Nicholls (10.1016/j.diabres.2022.110021_b0035) 2018; 3
Garvey (10.1016/j.diabres.2022.110021_b0130) 2003; 52
Haase (10.1016/j.diabres.2022.110021_b0085) 2015; 64
Mackey (10.1016/j.diabres.2022.110021_b0140) 2015; 38
Ouimet (10.1016/j.diabres.2022.110021_b0020) 2019; 124
Kunitake (10.1016/j.diabres.2022.110021_b0110) 1992; 33
Cochran (10.1016/j.diabres.2022.110021_b0045) 2021; 10
Davidson (10.1016/j.diabres.2022.110021_b0095) 2019; 15
Lee (10.1016/j.diabres.2022.110021_b0050) 2019; 104
Grundy (10.1016/j.diabres.2022.110021_b0150) 2019; 139
10.1016/j.diabres.2022.110021_b0115
Oda (10.1016/j.diabres.2022.110021_b0090) 2015; 22
Ahmed (10.1016/j.diabres.2022.110021_b0125) 2021; 64
References_xml – reference: S1–S2.
– volume: 18
  start-page: 416
  year: 2011
  end-page: 422
  ident: b0010
  article-title: Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
  publication-title: Nat Struct Mol Biol
– volume: 33
  start-page: 1807
  year: 1992
  end-page: 1816
  ident: b0110
  article-title: Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities
  publication-title: J Lipid Res
– volume: 59
  start-page: 1153
  year: 2010
  end-page: 1160
  ident: b0135
  article-title: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women
  publication-title: Diabetes
– volume: 18
  start-page: 712
  year: 2021
  end-page: 723
  ident: b0015
  article-title: High-density lipoproteins, reverse cholesterol transport and atherogenesis
  publication-title: Nat Rev Cardiol
– volume: 22
  start-page: 133
  year: 2015
  end-page: 141
  ident: b0090
  article-title: High-density lipoprotein cholesterol: origins and the path ahead
  publication-title: Curr Opin Endocrinol Diabetes Obes
– volume: 15
  start-page: 55
  year: 2019
  end-page: 61
  ident: b0095
  article-title: High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
  publication-title: Methodist Debakey Cardiovasc J
– volume: 11
  start-page: 171
  year: 2006
  end-page: 183
  ident: b0120
  article-title: Lipoproteins: When size really matters
  publication-title: Curr Opin Colloid Interface Sci
– reference: 203-12.
– volume: 167
  start-page: 1068
  year: 2007
  end-page: 1074
  ident: b0060
  article-title: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study
  publication-title: Arch Intern Med
– volume: 124
  start-page: 1505
  year: 2019
  end-page: 1518
  ident: b0020
  article-title: HDL and Reverse Cholesterol Transport
  publication-title: Circ Res
– volume: 8
  start-page: 237
  year: 2012
  end-page: 245
  ident: b0005
  article-title: The emerging role of HDL in glucose metabolism
  publication-title: Nat Rev Endocrinol
– volume: 104
  start-page: 5633
  year: 2019
  end-page: 5641
  ident: b0050
  article-title: HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
  publication-title: J Clin Endocrinol Metab
– volume: 38
  start-page: 628
  year: 2015
  end-page: 636
  ident: b0140
  article-title: Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis
  publication-title: Diabetes Care
– volume: 10
  start-page: 850
  year: 2021
  ident: b0045
  article-title: High Density Lipoproteins and Diabetes
  publication-title: Cells
– volume: 103
  start-page: 384
  year: 2014
  end-page: 394
  ident: b0100
  article-title: High-density lipoprotein, beta cells, and diabetes
  publication-title: Cardiovasc Res
– volume: 64
  start-page: 3328
  year: 2015
  end-page: 3333
  ident: b0085
  article-title: HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study
  publication-title: Diabetes
– volume: 3
  start-page: 806
  year: 2018
  ident: b0030
  article-title: Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
  publication-title: JAMA Cardiol
– reference: 1217-27.
– volume: 119
  start-page: 2103
  year: 2009
  end-page: 2111
  ident: b0070
  article-title: High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus
  publication-title: Circulation
– volume: 59
  start-page: 949
  year: 2013
  end-page: 958
  ident: b0105
  article-title: A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study
  publication-title: Clin Chem
– reference: HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017;
– volume: 3
  start-page: 815
  year: 2018
  ident: b0035
  article-title: Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
  publication-title: JAMA Cardiol
– volume: 64
  start-page: 656
  year: 2021
  end-page: 667
  ident: b0125
  article-title: HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study
  publication-title: Diabetologia
– reference: Feingold KR. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from:
– volume: 28
  start-page: 2013
  year: 2005
  end-page: 2018
  ident: b0055
  article-title: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study
  publication-title: Diabetes Care
– reference: .
– reference: HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;
– volume: 171
  start-page: 137
  year: 2014
  end-page: 142
  ident: b0080
  article-title: Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose
  publication-title: Eur J Endocrinol
– volume: 52
  start-page: 453
  year: 2003
  end-page: 462
  ident: b0130
  article-title: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
  publication-title: Diabetes
– volume: 98
  start-page: E1352
  year: 2013
  end-page: E1359
  ident: b0065
  article-title: Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study
  publication-title: J Clin Endocrinol Metab
– volume: 380
  start-page: 572
  year: 2012
  end-page: 580
  ident: b0040
  article-title: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
  publication-title: Lancet
– volume: 139
  start-page: e1082
  year: 2019
  end-page: e1143
  ident: b0150
  article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  publication-title: Circulation
– reference: Introduction: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;
– volume: 167
  start-page: 1068
  year: 2007
  ident: 10.1016/j.diabres.2022.110021_b0060
  article-title: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.167.10.1068
– volume: 28
  start-page: 2013
  issue: 8
  year: 2005
  ident: 10.1016/j.diabres.2022.110021_b0055
  article-title: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.8.2013
– volume: 64
  start-page: 3328
  year: 2015
  ident: 10.1016/j.diabres.2022.110021_b0085
  article-title: HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study
  publication-title: Diabetes
  doi: 10.2337/db14-1603
– volume: 59
  start-page: 949
  year: 2013
  ident: 10.1016/j.diabres.2022.110021_b0105
  article-title: A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2012.196949
– volume: 11
  start-page: 171
  issue: 2-3
  year: 2006
  ident: 10.1016/j.diabres.2022.110021_b0120
  article-title: Lipoproteins: When size really matters
  publication-title: Curr Opin Colloid Interface Sci
  doi: 10.1016/j.cocis.2005.11.006
– volume: 33
  start-page: 1807
  issue: 12
  year: 1992
  ident: 10.1016/j.diabres.2022.110021_b0110
  article-title: Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)41338-0
– volume: 38
  start-page: 628
  issue: 4
  year: 2015
  ident: 10.1016/j.diabres.2022.110021_b0140
  article-title: Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0645
– volume: 18
  start-page: 712
  issue: 10
  year: 2021
  ident: 10.1016/j.diabres.2022.110021_b0015
  article-title: High-density lipoproteins, reverse cholesterol transport and atherogenesis
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-021-00538-z
– ident: 10.1016/j.diabres.2022.110021_b0025
  doi: 10.1056/NEJMoa1300955
– volume: 10
  start-page: 850
  issue: 4
  year: 2021
  ident: 10.1016/j.diabres.2022.110021_b0045
  article-title: High Density Lipoproteins and Diabetes
  publication-title: Cells
  doi: 10.3390/cells10040850
– volume: 98
  start-page: E1352
  year: 2013
  ident: 10.1016/j.diabres.2022.110021_b0065
  article-title: Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-1680
– volume: 15
  start-page: 55
  year: 2019
  ident: 10.1016/j.diabres.2022.110021_b0095
  article-title: High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
  publication-title: Methodist Debakey Cardiovasc J
  doi: 10.14797/mdcj-15-1-55
– volume: 64
  start-page: 656
  issue: 3
  year: 2021
  ident: 10.1016/j.diabres.2022.110021_b0125
  article-title: HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study
  publication-title: Diabetologia
  doi: 10.1007/s00125-020-05320-3
– volume: 59
  start-page: 1153
  year: 2010
  ident: 10.1016/j.diabres.2022.110021_b0135
  article-title: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women
  publication-title: Diabetes
  doi: 10.2337/db09-1114
– ident: 10.1016/j.diabres.2022.110021_b0115
– ident: 10.1016/j.diabres.2022.110021_b0075
  doi: 10.1056/NEJMoa1706444
– volume: 22
  start-page: 133
  year: 2015
  ident: 10.1016/j.diabres.2022.110021_b0090
  article-title: High-density lipoprotein cholesterol: origins and the path ahead
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0000000000000139
– volume: 18
  start-page: 416
  issue: 4
  year: 2011
  ident: 10.1016/j.diabres.2022.110021_b0010
  article-title: Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.2028
– volume: 119
  start-page: 2103
  issue: 15
  year: 2009
  ident: 10.1016/j.diabres.2022.110021_b0070
  article-title: High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.843219
– volume: 103
  start-page: 384
  issue: 3
  year: 2014
  ident: 10.1016/j.diabres.2022.110021_b0100
  article-title: High-density lipoprotein, beta cells, and diabetes
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvu143
– volume: 171
  start-page: 137
  year: 2014
  ident: 10.1016/j.diabres.2022.110021_b0080
  article-title: Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-14-0195
– volume: 52
  start-page: 453
  issue: 2
  year: 2003
  ident: 10.1016/j.diabres.2022.110021_b0130
  article-title: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
  publication-title: Diabetes
  doi: 10.2337/diabetes.52.2.453
– volume: 3
  start-page: 806
  issue: 9
  year: 2018
  ident: 10.1016/j.diabres.2022.110021_b0030
  article-title: Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2018.2112
– volume: 3
  start-page: 815
  issue: 9
  year: 2018
  ident: 10.1016/j.diabres.2022.110021_b0035
  article-title: Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2018.2121
– volume: 124
  start-page: 1505
  issue: 10
  year: 2019
  ident: 10.1016/j.diabres.2022.110021_b0020
  article-title: HDL and Reverse Cholesterol Transport
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.119.312617
– volume: 8
  start-page: 237
  issue: 4
  year: 2012
  ident: 10.1016/j.diabres.2022.110021_b0005
  article-title: The emerging role of HDL in glucose metabolism
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2011.235
– volume: 104
  start-page: 5633
  year: 2019
  ident: 10.1016/j.diabres.2022.110021_b0050
  article-title: HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2019-01080
– volume: 380
  start-page: 572
  issue: 9841
  year: 2012
  ident: 10.1016/j.diabres.2022.110021_b0040
  article-title: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60312-2
– volume: 139
  start-page: e1082
  year: 2019
  ident: 10.1016/j.diabres.2022.110021_b0150
  article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  publication-title: Circulation
– ident: 10.1016/j.diabres.2022.110021_b0145
  doi: 10.2337/dc21-Sint
SSID ssj0006345
Score 2.3786194
Snippet To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional...
To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).AIMSTo learn how...
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 110021
SubjectTerms Fasting glucose
HDL-C/ApoA-I ratio
Quantile regression
Title Associations between the HDL-C/ApoA-I ratio and fasting glucose levels differ by glucose deciles, HDL-C/ApoA-I ratio ranges and sex
URI https://www.clinicalkey.com/#!/content/1-s2.0-S016882272200835X
https://dx.doi.org/10.1016/j.diabres.2022.110021
https://www.proquest.com/docview/2694963973
Volume 190
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6iIF7EJ76J4NFsa5Im6XFZlfV5UWFvpXkUFOkudgW9ePGPm2nT9YGieGybCSUz-TKTfDNBaC9htNCGMyLTQhCu_JzTPNHE2sRyGwtjHOx3XFyK_g0_HSSDKdRrc2GAVhmwv8H0Gq3DmyiMZjS6vY2uvLPi3UMqKa39iAFksHMJVt55ead5CMYbGqNQBFq_Z_FEdx3Y3_RRrQ8TKQVCfEwPflqfviB1vfwcL6D54DfibvNri2jKlUto9iKcjC-j1w_jXOHAvsLeu8P9w3PSi7qjYZec4FrfOC8tLvIKGM84cNbxPbCHKtxcmIL18-SDdcYjR7X_XUcPkJpQ1f1V7mkF3RwfXff6JFywQAxLxZhIw2OrfcSkjU55QZ1JlFSCyRQKm3EWOx-PWW251tQWaZFYSLnUB7lNacwSwVbRdDks3RrCirECaslLaTws5LnKmZGKQ7lDI4VV64i3w5qZUH0cLsG4z1qa2V0WtJGBNrJGG-uoMxEbNeU3fhMQrc6yNrfUo2HmF4jfBNVE8JMB_kV0tzWOzE9OOHHJSzd89I1EylM4OmUb_-9-E83BU8M63ELT44dHt-09obHeqU19B810T876l2_ycAX1
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZgK0EvVVtAPFpqpB7rTbAd2zmutkVLu8ulIO3Nih-RQCi7IotULlz443gSZ7dURVS9xh4r8tifZ-xvZhD6nDFaGssZkXkpCFdhzxmeGeJc5rhLhbUe7jsmZ2J0wb9Ps-kaGnaxMECrjNjfYnqD1vFLEmczmV9eJj-DsRLMQyopbeyI6Tp6xcP2hTIG_fsVz0Mw3vIYhSLQfRXGk1z14YIzuLXBT6QUGPEpPX7ugPoDqpvz5-QtehMNRzxo_-0dWvPVe7QxiU_jW-jht4mucaRf4WDe4dHXMRkmg_lsQE5xo3BcVA6XRQ2UZxxJ6_ga6EM1biumYHO3bHDeBuiov_xtoBuITaib8Wr_axtdnHw7H45IrLBALMvFgkjLU2eCy2SsyXlJvc2UVILJHDKbcZb64JA547gx1JV5mTmIuTTHhctpyjLBdlCvmlV-F2HFWAnJ5KW0AReKQhXMSsUh36GVwqk9xLtp1TamH4cqGNe645ld6agNDdrQrTb2UH8pNm_zb7wkIDqd6S64NMChDifES4JqKfhkBf6L6FG3OHTYnfDkUlR-dhs6iZzn8HbK9v9_-E9oc3Q-Gevx6dmPA_QaWloK4gfUW9zc-o_BLFqYw2bZPwLZrAeD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+between+the+HDL-C%2FApoA-I+ratio+and+fasting+glucose+levels+differ+by+glucose+deciles%2C+HDL-C%2FApoA-I+ratio+ranges+and+sex&rft.jtitle=Diabetes+research+and+clinical+practice&rft.au=Zhang%2C+Yuetao&rft.au=Wang%2C+Yue&rft.date=2022-08-01&rft.pub=Elsevier+B.V&rft.issn=0168-8227&rft.eissn=1872-8227&rft.volume=190&rft_id=info:doi/10.1016%2Fj.diabres.2022.110021&rft.externalDocID=S016882272200835X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8227&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8227&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8227&client=summon